Edmund S. Higgins, MD. Clinical Associate Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina.
Dr. Higgins reports stock ownership in Bristol-Myers-Squibb and Johnson & Johnson. Dr. Aiken has reviewed this educational activity and determined that there is no commercial bias as a result of this financial relationship.
Mark L. Ruffalo, MSW, DPsa. Editor in Chief, The Carlat Psychotherapy Report, psychotherapist in private practice in Tampa, Florida, and Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine. He has broad clinical experience in the psychoanalytic treatment of mood, personality, and psychosomatic disorders, and has particular interest in the psychotherapy of schizophrenia and borderline personality disorder.
Dr. Ruffalo has no financial relationships with companies related to this material.
Circe Cooke, MD. Child and adolescent psychiatrist, Presbyterian Healthcare Services, Albuquerque, NM.
Dr. Cooke has no financial relationships with companies related to this material.
Alexander El Sehamy, MD. Attending psychiatrist, Pediatric Emergency Behavioral Health Services, Cohen Children’s Medical Center, Northwell Health, Queens, NY.
Alan Schlechter, MD. Clinical associate professor, Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, NY.
Dr. El Sehamy and Dr. Schlechter have no financial relationships with companies related to this material.
Aydar Shaildayev, MD. Psychiatry resident, NYU Langone, New York, NY.
Eric Whitney, MD. Clinical assistant professor, Department of Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, NY.
Drs. Shaildayev and Whitney have no financial relationships with companies related to this material.
Julia Cromwell, MD. Medical Director, Senior Adult Psychiatry Unit, Salem Hospital, Salem, MA.
Christianne Gonzalez Davidson, MD candidate 2024. Tufts University School of Medicine, Boston, MA.
Paul A. Bryant, MD, Assistant Professor of Psychiatry; Stephanie Eng, MD, Fellow in Forensic Psychiatry; Melissa Lavoie, MD, Fellow in Forensic Psychiatry. Yale University, New Haven, CT.
Drs. Bryant, Eng, and Lavoie have no financial relationships with companies related to this material.
Stephen Wemakor, MD, Department of Psychiatry, Yale University, New Haven, CT; Noah Capurso, MD, MHS, Assistant Professor of Psychiatry, Yale University, & Editor-in-Chief, The Carlat Addiction Treatment Report.
Drs. Wemakor and Capurso have no financial relationships with companies related to this material.
J. Brandon Birath, PhD. Director of Psychology Training, Olive View-UCLA Medical Center, Los Angeles, CA.
Victoria Hendrick, MD. Chief, Inpatient Psychiatry, Olive View-UCLA Medical Center, Los Angeles, CA; Editor-in-Chief, The Carlat Hospital Psychiatry Report.
Dr. Birath and Dr. Hendrick have no financial relationships with companies related to this material.
Brian Holoyda, MD. Chief Psychiatrist, Contra Costa County Detention Health Services, Martinez, CA. Dr. Holoyda has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
